EAGLE PHARMS INC(EGRX)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- IV Rank (30D)
- 0
- Straddle Price
- $1.27
- P/C Vol Ratio
- 0.38
- Exchange
- OTC Link
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +1.44% | 4 |
| Feb | -3.47% | 4 |
| Mar | -0.95% | 4 |
| Apr | -8.50% | 4 |
| May | -8.62% | 4 |
| Jun | +7.17% | 4 |
| Jul | -5.49% | 4 |
| Aug | -5.28% | 4 |
| Sep | -11.57% | 4 |
| Oct | +9.95% | 4 |
| Nov | -17.82% | 3 |
| Dec | -8.48% | 3 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-10-02 | unknown | 34.41% | 36.24% | 1.05x | Exceeded |
- IV Rank (30D)
- 0
- IV Rank (7D)
- 0
- Avg IV
- 0.0%
- Straddle (30D)
- $1.27
- Straddle (7D)
- $1.27
- P/C Volume
- 0.38
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2024-03-01 | Scott Tarriff | 10%+ Owner | Tax (F) | −2,119 | $6.27 | -$13.3K | EDGAR |
| 2024-02-29 | Scott Tarriff | 10%+ Owner | Mixed | +9,796 | $6.44 | -$20.3K | EDGAR |
| 2024-02-29 | Brian Joseph Cahill | CHIEF FINANCIAL OFFICER | Mixed | +2,211 | $6.44 | -$10.2K | EDGAR |
| 2024-02-06 | Brian Joseph Cahill | CHIEF FINANCIAL OFFICER | Tax (F) | −934 | $5.85 | -$5.5K | EDGAR |
| 2024-01-09 | Brian Joseph Cahill | Chief Financial Officer | Tax (F) | −735 | $5.13 | -$3.8K | EDGAR |
| 2024-01-09 | Scott Tarriff | 10%+ Owner | Tax (F) | −4,322 | $5.13 | -$22.2K | EDGAR |
| 2023-12-22 | Michael Graves | Interim Executive Chair & PEO | Grant (A) | +293,000 opt | — | EDGAR | |
| 2023-12-20 | Brian Joseph Cahill | Chief Financial Officer | Tax (F) | −452 | $4.76 | -$2.2K | EDGAR |
| 2023-11-03 | Scott Tarriff | CEO | Sell (S) | −21,619 | $13.84 | -$299.3K | EDGAR |
| 2023-10-31 | Michael Graves | Director | Exer (M) | +9,360 | $4.94 | $46.2K | EDGAR |
| 2023-10-04 | Scott Tarriff | CEO | Sell (S) | −20,245 | $14.82 | -$300.0K | EDGAR |
| 2023-05-18 | Scott Tarriff | CEO | Sell (S) | −15,000 | $19.98 | -$299.7K | EDGAR |
| 2023-05-15 | Scott Tarriff | CEO | Sell (S) | −45,000 | $20.68 | -$930.7K | EDGAR |
| 2023-03-09 | LUCIANA BORIO | Director | Grant (A) | +16,253 opt | — | EDGAR | |
| 2023-03-09 | Robert Glenning | Director | Grant (A) | +16,253 opt | — | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Scott Tarriff | CEO | 1,453,244 | $3.11M | -$24.37M | 37 | 2024-03-01 |
| 2 | Douglas L Braunstein | Director | 810,365 | $1.73M | -$8.06M | 7 | 2019-09-19 |
| 3 | Hudson Executive Capital LP | Director | 749,708 | $1.60M | -$1.99M | 1 | 2019-10-23 |
| 4 | HEC Management GP LLC | Director | 732,777 | $1.57M | -$12.64M | 5 | 2019-10-28 |
| 5 | David Pernock | Pres & Chief Operating Officer | 54,625 | $116.9K | $76.9K | 17 | 2021-02-04 |
| 6 | Adrian Hepner | EVP and Chief Medical Officer | 48,784 | $104.4K | $0 | 6 | 2020-01-27 |
| 7 | Brian Joseph Cahill | CHIEF FINANCIAL OFFICER | 47,958 | $102.6K | $0 | 20 | 2024-02-29 |
| 8 | Pete A. Meyers | Chief Financial Officer | 43,615 | $93.3K | $44.4K | 7 | 2020-01-27 |
| 9 | Michael Shawn Moran | EVP, Chief Commercial Officer | 32,115 | $68.7K | $0 | 5 | 2022-03-02 |
| 10 | Jay Moorin | Director | 26,174 | $56.0K | -$70.97M | 10 | 2017-01-06 |
| 11 | STEVEN B RATOFF | Director | 22,684 | $48.5K | -$699.6K | 16 | 2023-03-09 |
| 12 | Richard A. Edlin | Director | 22,600 | $48.4K | $265.9K | 9 | 2023-03-09 |
| 13 | ALAIN SCHREIBER | Director | 18,477 | $39.5K | -$18.94M | 5 | 2017-04-27 |
| 14 | SANDER A FLAUM | Director | 13,714 | $29.3K | -$1.23M | 11 | 2019-03-06 |
| 15 | Michael Graves | Interim Executive Chair & PEO | 10,360 | $22.2K | $56.7K | 14 | 2023-12-22 |
| 16 | ProQuest Management LLC | 10%+ Owner | 9,360 | $20.0K | $0 | 1 | 2016-05-24 |
| 17 | ProQuest Financial LLC | 10%+ Owner | 7,277 | $15.6K | -$77.20M | 3 | 2017-03-29 |
| 18 | ProQuest Associates IV LLC | 10%+ Owner | 6,777 | $14.5K | -$252.45M | 9 | 2017-04-03 |
| 19 | ProQuest Investments IV, L.P. | 10%+ Owner | 6,777 | $14.5K | -$27.28M | 2 | 2017-05-15 |
| 20 | Steven L. Krill | EVP & Chief Scientific Officer | 3,000 | $6.4K | -$7.03M | 10 | 2018-01-09 |
| 21 | Judith Ng-Cashin | Chief Medical Officer | 2,000 | $4.3K | $0 | 2 | 2021-02-04 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.